A Major Shareholder's Exit: Why Dyadic International's Recent Insider Sales Demand Scrutiny

Related Articles

Stratus Properties: Major Shareholder Exit Confirms Liquidation Strategy

3 months ago

What Do Recent Major Shareholder Filings Signal for Faron Pharmaceuticals

4 months ago

Ethos Technologies: Why a Major Insider Exit Overshadows Bullish Growth

2 months ago

Arista Networks' Insider Sales: Diversification Amidst AI Growth Scrutiny

3 months ago

Category

You may also like

Stock News•1 months ago

Insider Sale: CEO Liquidates Nearly 40,000 Shares of Small-Cap Growth Stock

A CEO sold 39,103 shares at a weighted average price of $37.71, totaling ~$1.5 million, equal to 5% of their direct Class A stake. The transaction reduces insider ownership and may draw investor scrut...

IBTA

Share

Stock News•2 months ago

Executive Dumps Over 14,000 Shares of Biotech Stock, Valued at $2.3 Million

Biotech executive Ian Clark sold 14,000 shares valued at $2.3 million, after exercising options at $50.57 while the precision oncology company trades near $160 per share.

GH

Share

Stock News•3 months ago

What This Immunome Sale Means a Day Before a Big FDA Milestone

An Immunome insider sold 100K shares (~$2.4M) on July 6-7, 2026, representing 32% of their holdings, ahead of a major FDA milestone.

IMNM

Share